课题基金 / 基金详情

Genetic regulation of serotonin efflux in brain regions

Genetic regulation of serotonin efflux in brain regions
大脑区域血清素流出的基因调控
批准号:
6607102
负责人:
IRWIN LUCKI
金额:
$17.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-07-01 至 2007-06-30

项目摘要

项目成果

IRWIN LUCKI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall hypothesis of this proposal is that regional variations in 5-HT release are important determinants of the response to SSRIs and behavioral reactivity to stress and environmental stimuli. The results for our prior in vivo microdialysis and behavior studies in 5-HT receptor mutants guide the objectives for this renewal proposal. The first objective is to employ targeted pharmacological challenge procedures to establish that 5-HT efflux in different brain regions is regulated in a topographical pattern and to determine the extent that different 5-HT autoreceptors contribute to these regional effects. The second objective is to provide new information concerning the circuitry by which 5-HT1A receptors regulate 5-HT transmission and compensations for their absence using tissue specific and temporally inducible genetic deletion. The third objective will be to examine the efflux of 5-HT in different brain regions of wild-type and mutant mice during performance of behaviors on tests for anxiety and antidepressants. The final objective will be to examine interactions with catecholamine neurotransmitters that may be important for regulating 5-HT efflux. Taken together, the proposed research program will continue to examine systematically the utility of genetic regulation for determining specific changes in 5-HT release and behavior is that is related to the expression of affective behaviors and the effects of antidepressant drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kappa Receptor Antagonists as Rapid Acting Antidepressants
Kappa Receptor Antagonists as Rapid Acting Antidepressants
Buprenorphine for Depression and Anxiety
  • 批准号:
    8451367
  • 项目类别:
  • 资助金额:
    $38.4万
  • 财政年份:
    2012
  • 负责人:
    IRWIN LUCKI
  • 依托单位:
Buprenorphine for Depression and Anxiety
  • 批准号:
    8627211
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2012
  • 负责人:
    IRWIN LUCKI
  • 依托单位:
海外基金